Free Trial

Elite Pharmaceuticals (ELTP) SEC Filings & 10K Form

Elite Pharmaceuticals logo
$0.62 -0.05 (-7.49%)
(As of 11/21/2024 ET)

Recent Elite Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/18/2024
3:35 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:51 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:23 PM
Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
7:27 AM
Elite Pharmaceuticals (Subject)
Plassche Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:47 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:30 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:16 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
4:21 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
4:26 PM
Elite Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
3:30 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:56 PM
Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
Form 4/A
04/02/2024
3:58 PM
Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:06 PM
Elite Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2024
3:06 PM
Elite Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
3:55 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
1:21 PM
Elite Pharmaceuticals (Issuer)
Hakim Nasrat A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:20 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:20 PM
Elite Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
5:58 PM
Caskey Davis S (Reporting)
Elite Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
6:05 PM
Elite Pharmaceuticals (Issuer)
WHITNELL JEFFREY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
5:50 PM
Dash Barry H (Reporting)
Elite Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:ELTP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners